Reconstruction of the evolutionary dynamics of hepatitis C virus subtypes in Montenegro and the Balkan region

Infection, Genetics and Evolution

Volumn 17, Issue , 2013, Pages 223-230

  Zehender, Gianguglielmo ^a   Sorrentino, Chiara ^a   Lai, Alessia ^a   Ebranati, Erika ^a   Gabanelli, Elena ^a   Presti, Alessandra Lo ^b   Vujoševic, Danijela ^c   Lauševic, Dragan ^c   Terzić, Dragica ^d   Shkjezi, Renata ^e   Bino, Silvia ^f   Vratnica, Zoran ^c   Mugosa, Boban ^c   Galli, Massimo ^a   Ciccozzi, Massimo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c Institute of Public Health   (Montenegro)

^d UNIVERSITY OF MONTENEGRO   (Montenegro)

^e CATHOLIC UNIVERSITY OUR LADY OF GOOD COUNSEL   (Albania)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Genotypes; Hepatitis C virus; Montenegro; Phylodynamics; Phylogeographic; Subtypes

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIA; BALKAN PENINSULA; CONTROLLED STUDY; CYPRUS; DEMOGRAPHY; EPIDEMIC; EUROPE; EVOLUTION; FEMALE; GENE SEQUENCE; GENOTYPE; GREECE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS TYPE 1B; HEPATITIS C VIRUS TYPE 3A; HUMAN; IATROGENIC DISEASE; INDIAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MONTENEGRO (REPUBLIC); NONHUMAN; PAKISTAN; PHYLODYNAMICS; PHYLOGENY; PHYLOGEOGRAPHY; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; BAYES THEOREM; EVOLUTION, MOLECULAR; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; MONTENEGRO; PHYLOGENY; PHYLOGEOGRAPHY; RNA, VIRAL; SPATIO-TEMPORAL ANALYSIS; YOUNG ADULT;

EID: 84877823499     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.04.003     Document Type: Article

References (52)

1. Bacak V., et al. Hepatitis C virus infection and related risk factors among injection drug users in Montenegro. Eur. Addict. Res. 2012, 19:68-73.
2. Brant L.J., et al. Planning for the healthcare burden of hepatitis C infection: hepatitis C genotypes identified in England, 2002-2007. J. Clin. Virol. 2010, 48:115-119.
3. Chironna M., et al. HBV, HCV and HDV infections in Albanian refugees in Southern Italy (Apulia region). Epidemiol. Infect. 2000, 125:163-167.
4. Chironna M., et al. Prevalence of hepatitis virus infections in Kosovar refugees. Int. J. Infect. Dis. 2001, 5:209-213.
5. Ciccozzi M., et al. Genetic diversity of HIV type 1 in Montenegro. AIDS Res. Hum. Retroviruses 2010, 27:921-924.
6. Ciccozzi M., et al. Reconstruction of the evolutionary dynamics of the hepatitis C virus 1b epidemic in Turkey. Infect. Genet. Evol. 2011, 11:863-868.
7. Ciccozzi M., et al. Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users. J. Med. Virol. 2011, 83:1565-1570.
8. Cornberg M., et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int. 2011, 31(Suppl. 2):30-60.
9. Drummond A.J., Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 2007, 7:214.
10. Drummond A.J., et al. Bayesian coalescent inference of past population dynamics from molecular sequences. Mol. Biol. Evol. 2005, 22:1185-1192.
11. European Centre for Disease Prevention and Control Hepatitis B and C in the EU Neighbourhood: Prevalence, Burden of Disease and Screening Policies 2010, ECDC, Stockholm.
12. Guindon S., et al. PHYML Online - a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res. 2005, 33:W557-W559.
13. Gupte G.M., et al. Complete genome sequences of hepatitis C virus subtype 3i and 3a subtype isolates from India. Indian J. Gastroenterol. 2010, 29:101-105.
14. Harris K.A., et al. The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a. J. Med. Virol. 1999, 58:127-131.
15. Hauri A.M., et al. The global burden of disease attributable to contaminated injections given in health care settings. Int. J. STD AIDS 2004, 15:7-16.
16. Hoofnagle J.H. Hepatitis C: the clinical spectrum of disease. Hepatology 1997, 26:15S-20S.
17. Hope V.D., et al. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J. Viral. Hepat. 2010, 18:262-270.
18. Judd A., et al. Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro. BMC Infect. Dis. 2009, 9:14.
19. Kass R.E., Raftery A.E. Bayes factors. J. Am. Stat. Assoc. 1995, 90:773-795.
20. Khan A., et al. Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan. J. Med. Virol. 2009, 81:1189-1197.
21. Kurbanov F., et al. Hepatitis C virus molecular epidemiology in Uzbekistan. J. Med. Virol. 2003, 69:367-375.
22. Lanave C., et al. A new method for calculating evolutionary substitution rates. J. Mol. Evol. 1984, 20:86-93.
23. Lauer G.M., Walker B.D. Hepatitis C virus infection. N. Engl. J. Med. 2001, 345:41-52.
24. Lemey P., et al. Bayesian phylogeography finds its roots. PLoS Comput. Biol. 2009, 5:e1000520.
25. Lu L., et al. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J. Med. Virol. 2005, 75:538-549.
26. Mathei C., et al. The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium. J. Viral. Hepat. 2008, 15:399-408.
27. Morice Y., et al. Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J. Med. Virol. 2006, 78:1296-1303.
28. Nakano T., et al. An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver Int. 2012, 32:339-345.
29. Narahari S., et al. Prevalence and geographic distribution of hepatitis C Virus genotypes in Indian patient cohort. Infect. Genet. Evol. 2009, 9:643-645.
30. Nelson P.K., et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011, 378:571-583.
31. Pawlotsky J.M., et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J. Infect. Dis. 1995, 171:1607-1610.
32. Posada D., Buckley T.R. Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests. Syst. Biol. 2004, 53:793-808.
33. Pybus O.G., et al. The epidemic behavior of the hepatitis C virus. Science 2001, 292:2323-2325.
34. Pybus O.G., et al. The hepatitis C virus epidemic among injecting drug users. Infect. Genet. Evol. 2005, 5:131-139.
35. Pybus O.G., et al. Investigating the endemic transmission of the hepatitis C virus. Int. J. Parasitol. 2007, 37:839-849.
36. Ramia S., Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. Int. J. Infect. Dis. 2006, 10:272-277.
37. Rantala M., van de Laar M.J. Surveillance and epidemiology of hepatitis B and C in Europe - a review. Euro Surveill 2008, 13.
38. Rehman I.U., et al. Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan. Genet. Vaccines Ther. 2011, 9:2.
39. Ruzibakiev R., et al. Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in Uzbekistan. Intervirology 2001, 44:327-332.
40. Schmidt H.A., et al. TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics 2002, 18:502-504.
41. Simmonds P., et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005, 42:962-973.
42. Smith D.B., et al. The origin of hepatitis C virus genotypes. J. Gen. Virol. 1997, 78(Pt 2):321-328.
43. Stamenkovic G., et al. Distribution of HCV genotypes among risk groups in Serbia. Eur. J. Epidemiol. 2000, 16:949-954.
44. Svirtlih N., et al. Hepatitis C virus genotypes in Serbia and Montenegro: the prevalence and clinical significance. World J. Gastroenterol. 2007, 13:355-360.
45. Tamura K., et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28:2731-2739.
46. Thompson J.D., et al. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997, 25:4876-4882.
47. Tokita H., et al. Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group. J. Gen. Virol. 1994, 75:931-936.
48. Valliammai T., et al. Diversity of genotypes of hepatitis C virus in southern India. J. Gen. Virol. 1995, 76:711-716.
49. WHO Hepatitis C--global prevalence. Wkly. Epidemiol. Rec. 2000, 75:18-19. (update).
50. Zehender G., et al. Phylogeography and epidemiological history of West Nile virus genotype 1a in Europe and the Mediterranean basin. Infect. Genet. Evol. 2011, 11:646-653.
51. Zehender G., et al. Reconstruction of the epidemic history of hepatitis B virus genotype D in Albania. Infect. Genet. Evol. 2011, 12:291-298.
52. Zehender G., et al. Spatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean Basin. PLoS ONE 2012, 7:e37198.